• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Exopharm

Exopharm

  • Home
  • Products
  • Partnering
  • Science
  • Resources
    • ASX Announcements
    • Investor Information
    • News & Articles
    • Careers
  • About Us
    • Our Values
    • Our Story
    • Our Team
    • Board of Directors
  • Contact

Value in new medicines and ‘longer strides’

January 28, 2021 By Dr. Ian Dixon

“There are more than 150 listed biotech companies on the ASX, so you need to back a select shortlist to outperform. While the science is often complex, look for companies that are capable of taking longer strides over the medium term,” says Dr. Ian Dixon, Managing Director & Founder.

You can access the full Stockhead article here.

 

 

Filed Under: News, Opinion Articles

Footer

Resources

  • ASX Announcements
  • Investor Information
  • Board of Directors
  • News & Articles

Information

  • Contact
  • Partnering
  • Join Our Mailing List
  • Privacy, Terms and Conditions
  • Facebook
  • LinkedIn
  • Twitter
  • Vimeo
Copyright © 2021 · Exopharm · ACN 163 765 991 · info@exopharm.com
Level 17/31 Queen St, Melbourne VIC Australia 3000 · P: +61 (0)3 9111 0026 ·

Web Design by Mallee Blue Media